ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
Easy Street
|
523 |
96K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
523
|
96K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
Easy Street
|
219 |
45K |
2 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
219
|
45K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
Easy Street
|
219 |
45K |
1 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Easy Street
|
9 |
2.0K |
5 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
9
|
2.0K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Easy Street
|
241 |
48K |
0 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
241
|
48K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
Easy Street
|
523 |
96K |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
523
|
96K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Easy Street
|
241 |
48K |
7 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
241
|
48K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
|
|
Easy Street
|
22 |
6.0K |
5 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
22
|
6.0K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Easy Street
|
241 |
48K |
1 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
241
|
48K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Easy Street
|
506 |
95K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
506
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Easy Street
|
506 |
95K |
2 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
506
|
95K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Easy Street
|
506 |
95K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
506
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Easy Street
|
506 |
95K |
9 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
506
|
95K
|
9
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
Easy Street
|
89 |
24K |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
89
|
24K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Results of Meeting
|
|
Easy Street
|
53 |
7.5K |
6 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
53
|
7.5K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Results of Meeting
|
|
Easy Street
|
53 |
7.5K |
0 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
53
|
7.5K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
Easy Street
|
14 |
2.4K |
5 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
14
|
2.4K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
Easy Street
|
55 |
10K |
0 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
55
|
10K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
Easy Street
|
55 |
10K |
3 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
55
|
10K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Easy Street
|
30 |
5.5K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
30
|
5.5K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Second HREC Approval for IIH EVOLVE Phase III Clinical Trial
|
|
Easy Street
|
15 |
4.8K |
3 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
15
|
4.8K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Second HREC Approval for IIH EVOLVE Phase III Clinical Trial
|
|
Easy Street
|
15 |
4.8K |
0 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
15
|
4.8K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Virtual ASX Small and Mid-Cap Conference
|
|
Easy Street
|
16 |
3.8K |
6 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
16
|
3.8K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
Easy Street
|
47 |
13K |
3 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
Easy Street
|
47 |
13K |
0 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
Easy Street
|
39 |
7.5K |
1 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
39
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
MST Financial IXC Presentation - July 14th 2022
|
|
Easy Street
|
33 |
7.2K |
5 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
33
|
7.2K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
Easy Street
|
142 |
38K |
8 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
142
|
38K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
Easy Street
|
142 |
38K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
142
|
38K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
Easy Street
|
142 |
38K |
4 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
142
|
38K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Easy Street
|
110 |
17K |
0 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
110
|
17K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Easy Street
|
110 |
17K |
2 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
110
|
17K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Easy Street
|
110 |
17K |
1 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
110
|
17K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
1 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
287
|
58K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
0 |
21/05/22 |
21/05/22 |
ASX - By Stock
|
287
|
58K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Aerospace Medical Association Meeting
|
|
Easy Street
|
4 |
1.4K |
7 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
4
|
1.4K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
Easy Street
|
142 |
38K |
1 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
142
|
38K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
Easy Street
|
142 |
38K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
142
|
38K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Half Yearly Report and Accounts
|
|
Easy Street
|
39 |
8.7K |
5 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
39
|
8.7K
|
5
|
|
ASX - By Stock
|
NTO |
Re:
Ann: Nitro Q4 2021 Quarterly Activities Report and Appendix 4C
|
|
Easy Street
|
15 |
11K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
15
|
11K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
2 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
287
|
58K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: New Executive Director and Chairman Agreements
|
|
Easy Street
|
20 |
3.2K |
4 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
20
|
3.2K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: New Executive Director and Chairman Agreements
|
|
Easy Street
|
20 |
3.2K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
20
|
3.2K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: New Executive Director and Chairman Agreements
|
|
Easy Street
|
20 |
3.2K |
4 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
20
|
3.2K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
287
|
58K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
2 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
287
|
58K
|
2
|
|
ASX - By Stock
|
TYR |
Re:
Ann: COVID-19 Trading Update 95 - Week Ended 7 January 2022
|
|
Easy Street
|
26 |
9.5K |
0 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
26
|
9.5K
|
0
|
|
ASX - By Stock
|
TYR |
Re:
Ann: COVID-19 Trading Update 95 - Week Ended 7 January 2022
|
|
Easy Street
|
26 |
9.5K |
4 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
26
|
9.5K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
Easy Street
|
287 |
58K |
5 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
287
|
58K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appointment IIH EVOLVE Phase III Trial Steering Group Chair
|
|
Easy Street
|
9 |
2.4K |
2 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
9
|
2.4K
|
2
|
|